Screener
Ligand Pharmaceuticals LGND Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's asset turnover?
- Ligand Pharmaceuticals (LGND) reported asset turnover of 0.2× in Q2 2026.
- How has Ligand Pharmaceuticals's asset turnover changed year-over-year?
- Ligand Pharmaceuticals's asset turnover decreased by 10.3% year-over-year, from 0.2× to 0.2×.
- What is the long-term trend for Ligand Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's asset turnover has grown at a 10.4% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Ligand Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude